DK1896031T3 - Thiazolopyrimidiner til anvendelse i terapi - Google Patents

Thiazolopyrimidiner til anvendelse i terapi

Info

Publication number
DK1896031T3
DK1896031T3 DK06744265T DK06744265T DK1896031T3 DK 1896031 T3 DK1896031 T3 DK 1896031T3 DK 06744265 T DK06744265 T DK 06744265T DK 06744265 T DK06744265 T DK 06744265T DK 1896031 T3 DK1896031 T3 DK 1896031T3
Authority
DK
Denmark
Prior art keywords
therapy
thiazolopyrimidines
alkyl
group
nhalkyl
Prior art date
Application number
DK06744265T
Other languages
English (en)
Inventor
Fei-Yeu Zhao
Alistair Kerr Dixon
Johnathan Mark Treherne
Chizuko Koseki
Original Assignee
Sosei Group Corp
Neurosolutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei Group Corp, Neurosolutions Ltd filed Critical Sosei Group Corp
Application granted granted Critical
Publication of DK1896031T3 publication Critical patent/DK1896031T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK06744265T 2005-06-20 2006-06-19 Thiazolopyrimidiner til anvendelse i terapi DK1896031T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0512554.7A GB0512554D0 (en) 2005-06-20 2005-06-20 Compounds for use in therapy
PCT/GB2006/002248 WO2006136806A1 (en) 2005-06-20 2006-06-19 Thiazolopyrimidines for use in therapy

Publications (1)

Publication Number Publication Date
DK1896031T3 true DK1896031T3 (da) 2009-05-11

Family

ID=34855848

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06744265T DK1896031T3 (da) 2005-06-20 2006-06-19 Thiazolopyrimidiner til anvendelse i terapi

Country Status (19)

Country Link
US (1) US8349845B2 (da)
EP (1) EP1896031B1 (da)
JP (1) JP5055474B2 (da)
KR (1) KR20080076897A (da)
CN (1) CN101355947B (da)
AT (1) ATE419853T1 (da)
AU (1) AU2006260714B2 (da)
BR (1) BRPI0614386A2 (da)
CA (1) CA2612865C (da)
DE (1) DE602006004735D1 (da)
DK (1) DK1896031T3 (da)
ES (1) ES2323981T3 (da)
GB (1) GB0512554D0 (da)
IL (1) IL188061A0 (da)
NO (1) NO20080049L (da)
NZ (1) NZ564170A (da)
PT (1) PT1896031E (da)
WO (1) WO2006136806A1 (da)
ZA (1) ZA200711062B (da)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564591A (en) * 1978-11-10 1980-05-15 Teijin Ltd Thiazolo 3, 2-a pyrimidine derivative, its preparation, and drug comprising it
JPS5566592A (en) * 1978-11-13 1980-05-20 Teijin Ltd 7-alkoxythiazolo 3,2-a pyrimidine derivative, its preparation, and drug containing the same
WO1981003174A1 (fr) * 1980-04-28 1981-11-12 Teijin Ltd Derives de thiazolo (3,2-a) pyrimidine, leur procede de preparation, et medicaments les contenant

Also Published As

Publication number Publication date
JP5055474B2 (ja) 2012-10-24
KR20080076897A (ko) 2008-08-20
JP2008543918A (ja) 2008-12-04
EP1896031B1 (en) 2009-01-07
IL188061A0 (en) 2011-08-01
GB0512554D0 (en) 2005-07-27
NZ564170A (en) 2011-03-31
HK1108842A1 (en) 2008-05-23
DE602006004735D1 (de) 2009-02-26
CN101355947B (zh) 2013-06-05
NO20080049L (no) 2008-01-17
PT1896031E (pt) 2009-04-15
US20100216819A1 (en) 2010-08-26
ZA200711062B (en) 2010-06-30
AU2006260714B2 (en) 2008-11-13
CA2612865A1 (en) 2006-12-28
CA2612865C (en) 2013-03-26
WO2006136806A1 (en) 2006-12-28
ATE419853T1 (de) 2009-01-15
US8349845B2 (en) 2013-01-08
ES2323981T3 (es) 2009-07-28
BRPI0614386A2 (pt) 2011-03-22
CN101355947A (zh) 2009-01-28
AU2006260714A1 (en) 2006-12-28
EP1896031A1 (en) 2008-03-12

Similar Documents

Publication Publication Date Title
BR112014003237A2 (pt) compostos de indazol, composições e métodos de uso
ECSP067080A (es) DIFENILIMIDAZOPIRIMIDINA Y AMINAS IMIDAZOL COMO INHIBIDORES DE ß-SECRETASA
GEP20125425B (en) Biaryl ether urea compounds
SE0301882D0 (sv) New use I
BRPI0416628A (pt) uso de compostos orgánicos
SE0301886D0 (sv) New use V
SE0301888D0 (sv) New use VII
ATE536349T1 (de) In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
WO2008022024A3 (en) Imidazole amines as inhibitors of beta-secretase
EA200801997A1 (ru) Новые соединения
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
ATE440833T1 (de) Antithrombotische diamide
CY1109743T1 (el) Παραγωγα των 2-βενζοϋλο-ιμιδαζοπυριδινων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
ATE533489T1 (de) Behandlung von multiplem myelom
EA200800302A1 (ru) Применение производных и аналогов тиазола при лечении рака
SE0401465D0 (sv) New substituted piperdines as modulators of dopamine neurotransmission
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
SE0200198D0 (sv) New use
AR043327A1 (es) Uso de inhibidores de quinurenina 3- hidroxilasa para el tratamiento de la diabetes
NO20070250L (no) S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor
IL188061A0 (en) Thiazolopyrimidines for use in therapy
EA200970615A1 (ru) Соединения имидазолидинониламинопиримидина для лечения рака
SE0301885D0 (sv) New use IV
SE0301884D0 (sv) New use III